Literature DB >> 16369025

Genome engineering in Bacillus anthracis using Cre recombinase.

Andrei P Pomerantsev1, Ramakrishnan Sitaraman, Craig R Galloway, Violetta Kivovich, Stephen H Leppla.   

Abstract

Genome engineering is a powerful method for the study of bacterial virulence. With the availability of the complete genomic sequence of Bacillus anthracis, it is now possible to inactivate or delete selected genes of interest. However, many current methods for disrupting or deleting more than one gene require use of multiple antibiotic resistance determinants. In this report we used an approach that temporarily inserts an antibiotic resistance marker into a selected region of the genome and subsequently removes it, leaving the target region (a single gene or a larger genomic segment) permanently mutated. For this purpose, a spectinomycin resistance cassette flanked by bacteriophage P1 loxP sites oriented as direct repeats was inserted within a selected gene. After identification of strains having the spectinomycin cassette inserted by a double-crossover event, a thermo-sensitive plasmid expressing Cre recombinase was introduced at the permissive temperature. Cre recombinase action at the loxP sites excised the spectinomycin marker, leaving a single loxP site within the targeted gene or genomic segment. The Cre-expressing plasmid was then removed by growth at the restrictive temperature. The procedure could then be repeated to mutate additional genes. In this way, we sequentially mutated two pairs of genes: pepM and spo0A, and mcrB and mrr. Furthermore, loxP sites introduced at distant genes could be recombined by Cre recombinase to cause deletion of large intervening regions. In this way, we deleted the capBCAD region of the pXO2 plasmid and the entire 30 kb of chromosomal DNA between the mcrB and mrr genes, and in the latter case we found that the 32 intervening open reading frames were not essential to growth.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16369025      PMCID: PMC1346652          DOI: 10.1128/IAI.74.1.682-693.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  The demonstration of bacterial capsules and slime.

Authors:  J P DUGUID
Journal:  J Pathol Bacteriol       Date:  1951-10

2.  A novel sporulation-control gene (spo0M) of Bacillus subtilis with a sigmaH-regulated promoter.

Authors:  W D Han; S Kawamoto; Y Hosoya; M Fujita; Y Sadaie; K Suzuki; Y Ohashi; F Kawamura; K Ochi
Journal:  Gene       Date:  1998-09-14       Impact factor: 3.688

3.  Characterization of the gene for a protein kinase which phosphorylates the sporulation-regulatory proteins Spo0A and Spo0F of Bacillus subtilis.

Authors:  M Perego; S P Cole; D Burbulys; K Trach; J A Hoch
Journal:  J Bacteriol       Date:  1989-11       Impact factor: 3.490

4.  Isolation of an asporogenic (spoOA) protective antigen-producing strain of Bacillus anthracis.

Authors:  P L Worsham; M R Sowers
Journal:  Can J Microbiol       Date:  1999-01       Impact factor: 2.419

5.  [Behavior of heterologous recombinant plasmid pCET in cells of Bacillus anthracis].

Authors:  A P Pomerantsev; N A Staritsyn
Journal:  Genetika       Date:  1996-04

6.  Fermentation, purification, and characterization of protective antigen from a recombinant, avirulent strain of Bacillus anthracis.

Authors:  J W Farchaus; W J Ribot; S Jendrek; S F Little
Journal:  Appl Environ Microbiol       Date:  1998-03       Impact factor: 4.792

7.  Regulation of the Bacillus anthracis protective antigen gene: CO2 and a trans-acting element activate transcription from one of two promoters.

Authors:  T M Koehler; Z Dai; M Kaufman-Yarbray
Journal:  J Bacteriol       Date:  1994-02       Impact factor: 3.490

8.  New thermosensitive plasmid for gram-positive bacteria.

Authors:  E Maguin; P Duwat; T Hege; D Ehrlich; A Gruss
Journal:  J Bacteriol       Date:  1992-09       Impact factor: 3.490

9.  Demonstration of a capsule plasmid in Bacillus anthracis.

Authors:  B D Green; L Battisti; T M Koehler; C B Thorne; B E Ivins
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

10.  The transformation frequency of plasmids into Bacillus anthracis is affected by adenine methylation.

Authors:  R Marrero; S L Welkos
Journal:  Gene       Date:  1995-01-11       Impact factor: 3.688

View more
  48 in total

Review 1.  Occurrence, recognition, and reversion of spontaneous, sporulation-deficient Bacillus anthracis mutants that arise during laboratory culture.

Authors:  Inka Sastalla; Stephen H Leppla
Journal:  Microbes Infect       Date:  2011-11-28       Impact factor: 2.700

2.  Accidental selection and intentional restoration of sporulation-deficient Bacillus anthracis mutants.

Authors:  Inka Sastalla; M J Rosovitz; Stephen H Leppla
Journal:  Appl Environ Microbiol       Date:  2010-07-16       Impact factor: 4.792

3.  Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice.

Authors:  Shihui Liu; Sharmina Miller-Randolph; Devorah Crown; Mahtab Moayeri; Inka Sastalla; Shu Okugawa; Stephen H Leppla
Journal:  Cell Host Microbe       Date:  2010-11-18       Impact factor: 21.023

4.  Key tissue targets responsible for anthrax-toxin-induced lethality.

Authors:  Shihui Liu; Yi Zhang; Mahtab Moayeri; Jie Liu; Devorah Crown; Rasem J Fattah; Alexander N Wein; Zu-Xi Yu; Toren Finkel; Stephen H Leppla
Journal:  Nature       Date:  2013-08-28       Impact factor: 49.962

5.  MyD88-dependent signaling protects against anthrax lethal toxin-induced impairment of intestinal barrier function.

Authors:  Shu Okugawa; Mahtab Moayeri; Michael A Eckhaus; Devorah Crown; Sharmina Miller-Randolph; Shihui Liu; Shizuo Akira; Stephen H Leppla
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

6.  Marker removal in staphylococci via Cre recombinase and different lox sites.

Authors:  Martina Leibig; Bernhard Krismer; Martina Kolb; Alexandra Friede; Friedrich Götz; Ralph Bertram
Journal:  Appl Environ Microbiol       Date:  2007-12-28       Impact factor: 4.792

7.  Dissecting the urokinase activation pathway using urokinase-activated anthrax toxin.

Authors:  Shihui Liu; Thomas H Bugge; Arthur E Frankel; Stephen H Leppla
Journal:  Methods Mol Biol       Date:  2009

8.  A Bacillus anthracis strain deleted for six proteases serves as an effective host for production of recombinant proteins.

Authors:  Andrei P Pomerantsev; Olga M Pomerantseva; Mahtab Moayeri; Rasem Fattah; Cynthia Tallant; Stephen H Leppla
Journal:  Protein Expr Purif       Date:  2011-08-07       Impact factor: 1.650

9.  A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model.

Authors:  Mahtab Moayeri; Clinton E Leysath; Jacqueline M Tremblay; Catherine Vrentas; Devorah Crown; Stephen H Leppla; Charles B Shoemaker
Journal:  J Biol Chem       Date:  2015-01-06       Impact factor: 5.157

10.  Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine component.

Authors:  Joanna Kubler-Kielb; Evgeny Vinogradov; Haijing Hu; Stephen H Leppla; John B Robbins; Rachel Schneerson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.